Click here to advertise on CatholicCulture.org

Cardinal warns against FDA plans to approve abortifacient Ulipristal

Catholic World News - June 21, 2010

Cardinal Daniel DiNardo of Galveston-Houston, chairman of the US bishops’ Committee on Pro-Life Activities, warned of the abortifacient nature of a new drug, Ulipristal, in a June 17 letter.

“I am writing because of grave concern over the FDA’s current process for approving the drug Ulipristal (with the proposed trade name of Ella) for use as an ‘emergency contraceptive,’” the cardinal wrote. “Ulipristal is a close analogue to the abortion drug RU-486, with the same biological effect-- that is, it can disrupt an established pregnancy weeks after conception has taken place.”

“This drug is contraindicated for women who are or may be pregnant,” he continued. “Yet its proposed use here is targeted precisely at women who may already have conceived, as it would be administered within five days after ‘unprotected’ sex or contraceptive failure. No existing pregnancy test can exclude the possibility that a new life has been conceived in this time frame. Indeed, advocates praise this drug as an advance precisely because it seems to retain its full efficacy five days after intercourse-- that is, after the opportunity to prevent fertilization has passed.”

“Millions of American women, even those willing to use a contraceptive to prevent fertilization in various circumstances, would personally never choose to have an abortion,” the cardinal added. “They would be ill served by a misleading campaign to present Ulipristal simply as a ‘contraceptive.’ In fact, FDA approval for that purpose would likely make the drug available for ‘off-label’ use simply as an abortion drug-- including its use by unscrupulous men with the intent of causing an early abortion without a woman's knowledge or consent.”

“The Administration’s support for broad access to contraception has been defended as serving the goal of reducing abortions,” he concluded. “Plans for approving a known abortion-causing drug as a ‘contraceptive’ for American women is not consistent with the stated policy of the Administration on these matters.”

Additional sources for this story
Some links will take you to other sites, in a new window.

An appeal from our founder, Dr. Jeffrey Mirus:

Dear reader: If you found the information on this page helpful in your pursuit of a better Catholic life, please support our work with a donation. Your donation will help us reach seven million Truth-seeking readers worldwide this year. Thank you!

Progress toward our April expenses ($26,348 to go):
$35,000.00 $8,651.70
75% 25%
Sound Off! CatholicCulture.org supporters weigh in.

All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a donor, log in to see the comment form; otherwise please support our work, and Sound Off!

Show 1 Comments? (Hidden)Hide Comments
  • Posted by: lauriem5377 - Jun. 22, 2010 5:25 AM ET USA

    Thank you to our Bishops for speaking out on this drug and identifying the numerous and serious issues related to its use. Where are our Catholic doctors who should be speaking out well before this drug gets approval?

Subscribe for free
Click here to advertise on CatholicCulture.org
Shop Amazon

Recent Catholic Commentary

Mysteries, again and again! 20 hours ago
Tips for getting comfortable with evangelization 23 hours ago
The Shroud of Turin on Display (and an odd canonical case against it) April 16
The Vatican says the LCWR is acting Catholic. And that's news. April 16
The Truth about the Armenian Genocide April 15

Top Catholic News

Most Important Stories of the Last 30 Days
Pope challenges world leaders' silence on persecution of Christians CWN - April 6
Pope outlines plans for the extraordinary jubilee of mercy CWN - April 13
Vatican completes doctrinal assessment of Leadership Conference of Women Religious CWN - April 16